Search Results - "El. Salem, Amal"
-
1
Empagliflozin, SGLT2 inhibitor, attenuates renal fibrosis in rats exposed to unilateral ureteric obstruction: potential role of klotho expression
Published in Naunyn-Schmiedeberg's archives of pharmacology (01-12-2018)“…Chronic kidney disease (CKD) is a global healthcare problem; however until now, there is no effective treatment that can stop its progression. In this study,…”
Get full text
Journal Article -
2
Rebamipide protects against experimentally induced intestinal ischemia/reperfusion-promoted liver damage: Impact on SIRT1/β-catenin/FOXO1and NFκB signaling
Published in International immunopharmacology (01-06-2023)“…•Intestinal I/R is a life-threatening condition associated with high morbidity and mortality rates.•Intestinal I/R is suggested to be the principal cause of…”
Get full text
Journal Article -
3
Metformin, sitagliptin, and liraglutide modulate serum retinol-binding protein-4 level and adipocytokine production in type 2 diabetes mellitus rat model
Published in Canadian journal of physiology and pharmacology (01-12-2018)“…Many adipocytokines correlate with obesity and insulin resistance. We examined the effects of metformin, sitagliptin, and liraglutide in diabetic rats. Group…”
Get more information
Journal Article -
4
Empagliflozin, SGLT 2 inhibitor, attenuates renal fibrosis in rats exposed to unilateral ureteric obstruction: potential role of klotho expression
Published in Naunyn-Schmiedeberg's archives of pharmacology (01-12-2018)“…Chronic kidney disease (CKD) is a global healthcare problem; however until now, there is no effective treatment that can stop its progression. In this study,…”
Get full text
Journal Article